Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -33.85%846K | -26.72%1.13M | 1.62%880K | 65.03%4.75M | 6.81%1.07M | 99.84%1.28M | 162.69%1.54M | 32.21%866K | -3.42%2.88M | -21.17%998K |
| Selling and administrative expenses | -46.48%243K | 39.02%709K | -9.80%405K | -6.22%1.84M | -40.68%452K | 6.07%454K | 38.59%510K | 11.69%449K | -10.50%1.96M | -20.46%762K |
| -General and administrative expense | -46.48%243K | 39.02%709K | -9.80%405K | -6.22%1.84M | -40.68%452K | 6.07%454K | 38.59%510K | 11.69%449K | -10.50%1.96M | -20.46%762K |
| Research and development costs | 104.00%102K | -86.03%19K | -90.58%13K | 110.92%367K | -6.52%43K | 21.95%50K | 209.09%136K | 220.93%138K | 324.39%174K | 187.50%46K |
| Depreciation amortization depletion | ---- | -9.96%226K | 22,400.00%225K | ---- | ---- | 18,800.00%189K | --251K | --1K | ---- | ---- |
| -Depreciation and amortization | ---- | -9.96%226K | 22,400.00%225K | ---- | ---- | 18,800.00%189K | --251K | --1K | ---- | ---- |
| Other operating expenses | -35.35%501K | -72.71%176K | -14.75%237K | 241.55%2.55M | 194.33%571K | 355.88%775K | 268.57%645K | 32.38%278K | 0.13%746K | -33.10%194K |
| Operating profit | 33.85%-846K | 26.72%-1.13M | -1.62%-880K | -65.03%-4.75M | -6.81%-1.07M | -99.84%-1.28M | -162.69%-1.54M | -32.21%-866K | 3.42%-2.88M | 21.17%-998K |
| Net non-operating interest income (expenses) | -94.64%-109K | -133.33%-119K | -8,700.00%-86K | -703.57%-169K | -3,050.00%-63K | -1,033.33%-56K | -950.00%-51K | -94.44%1K | -17.65%28K | -110.53%-2K |
| Non-operating interest income | --0 | --0 | --0 | -13.95%37K | 33.33%4K | -25.00%9K | 80.00%18K | -66.67%6K | 2.38%43K | -84.21%3K |
| Non-operating interest expense | 67.69%109K | 72.46%119K | 1,620.00%86K | 1,273.33%206K | 1,240.00%67K | 983.33%65K | 1,625.00%69K | --5K | 87.50%15K | --5K |
| Other net income (expenses) | 41.38%-34K | -443.24%-201K | -3,875.86%-1.1M | -3,275.86%-979K | -200.00%-58K | 87.24%-37K | -107.24%-21K | 100.04%29K | 99.96%-29K | |
| Gain on sale of security | ---46K | ---218K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | --42K | --2K | ---- | ---950K | ---950K | --0 | --0 | ---- | --0 | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --950K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Gain on sale of property,plant,equipment | --42K | --2K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---30K | --15K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 29.00%-989K | 11.04%-1.45M | -9.03%-966K | -113.14%-6.02M | -104.86%-2.11M | -141.84%-1.39M | -87.14%-1.63M | -155.33%-886K | 95.90%-2.82M | 98.46%-1.03M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 29.00%-989K | 11.04%-1.45M | -9.03%-966K | -113.14%-6.02M | -104.86%-2.11M | -141.84%-1.39M | -87.14%-1.63M | -155.33%-886K | 95.90%-2.82M | 98.46%-1.03M |
| Net income continuous operations | 29.00%-989K | 11.04%-1.45M | -9.03%-966K | -113.14%-6.02M | -104.86%-2.11M | -141.84%-1.39M | -87.14%-1.63M | -155.33%-886K | 95.90%-2.82M | 98.46%-1.03M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 29.00%-989K | 11.04%-1.45M | -9.03%-966K | -113.14%-6.02M | -104.86%-2.11M | -141.84%-1.39M | -87.14%-1.63M | -155.33%-886K | 95.90%-2.82M | 98.46%-1.03M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 29.00%-989K | 11.04%-1.45M | -9.03%-966K | -113.14%-6.02M | -104.86%-2.11M | -141.84%-1.39M | -87.14%-1.63M | -155.33%-886K | 95.90%-2.82M | 98.46%-1.03M |
| Diluted earnings per share | 0 | 0 | 0 | 0.00%-0.01 | 0 | 0 | 0 | 0 | 93.33%-0.01 | 95.72%-0.0062 |
| Basic earnings per share | 0 | 0 | 0 | 0.00%-0.01 | 0 | 0 | 0 | 0 | 93.33%-0.01 | 95.72%-0.0062 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.